Clinical TrialsSearch results
Number of results: 857
No Longer Recruiting
- A phase II randomized clinical trial to determine the effectiveness of goreisan and saireito for lower limb lymphedema in women treated for gynecologic cancer
- Lower Limb Lymphedema
- Kajiyama Hiroaki
- 2019-04-18
No Longer Recruiting
- A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety and Efficacy of Longeveron Allogeneic Human Mesenchymal Stem Cells (LMSC) Administration in Patients With Aging Frailty.
- Aging Frailty
- Matsui Yasumoto
- 2020-08-04
No Longer Recruiting
- Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF)
- Ischemic Stroke
- Yamagami Hiroshi
- 2019-03-27
No Longer Recruiting
- The combination therapy with Eldecalcitol and Ibandronate sodium
- Patients diagnosed with osteopenia among patients with gastric cancer after gastrectomy
- Murakami Hideki
- 2020-11-06
Recruiting
- [M19-973] (OptIMMize-2): Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977
- Psoriasis
- Fujimura Kimino
- 2022-11-17
Recruiting
- 3D gait analysis and L-DOPA in Dravet syndrome.
- Dravet syndrome(severe myoclonic epilepsy in infant)
- Natsume Jun
- 2020-02-17
Recruiting
- A clinical study of the safety and efficacy of anti-epileptic drug Zonisamide for treatment of radiculopaty
- Cervical spondylotic radiculopathy
- Imagama Shiro
- 2021-07-21
Recruiting
- A Comparative Study of the Effects of Cognitive Functioning with and without Hearing Aid Intervention for People with Hearing Loss
- Hearing loss
- Kanzaki Sho
- 2024-03-07
Recruiting
- A Modular Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Lmmunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0305 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Relapsed or Refractory Multiple Myeloma
- Relapsed or Refractory Multiple Myeloma
- Hibi Kazushige
- 2024-04-03
Recruiting
- A multicenter phase II study of brigatinib for patients with metastatic solid tumor
- ALK-fusion gene-positive advanced/recurrent solid tumors except for non-small cell lung cancer
- Toshiki Masuishi
- 2022-02-18